Skip to content

Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain

Executive Control, Processing Speed and Memory Function in Long- Term Peripheral Neuropathic Pain and Fibromyalgia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02824588
Acronym
NEPA
Enrollment
82
Registered
2016-07-06
Start date
2016-09-30
Completion date
2018-09-02
Last updated
2018-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Neuropathic Pain, Working Memory Deficits

Keywords

Pain, Working memory

Brief summary

The goal of this project is to investigate and improve executive control function in two distinct pain conditions, namely neuropathic pain and fibromyalgia (FM). It is hypothesized that there is a significant difference in the executive control function of patients with neuropathic pain and FM pain. It is also hypothesized that all participants with poor executive control functioning will report significant improvements in pain intensity, functioning and cognitive complaints following cognitive training. The study tests and influence the working memory concepts of inhibition, updating and flexibility through an experimental, cross-over treatment design. To perform the experiment, we will recruit 160 participants (80 with neuropathic pain and 80 with FM) from the Departments of pain management and research at St Olav's University Hospital and Oslo University Hospital (OUS). The proposed design will be able to determine whether or not executive control, processing speed and memory function differs in two distinct populations of pain patients. Moreover, whether impairments are amended by computerized training.

Interventions

BEHAVIORALWorking Memory Training

Training mental flexibility

BEHAVIORALInternet use

Used as control for time spent on computer

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of fibromyalgia or neuropathic pain * Confirmed objective cognitive impairments on the CANTAB battery compared to IQ control

Exclusion criteria

* Mania, suicidal ideation and/or active psychosis * No objective cognitive impairments * Personality disorders * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Objective neuropsychological tests36 weeksCANTAB test battery

Secondary

MeasureTime frameDescription
Stress regulation36 weeksHair cortisol
Symptoms of depression36 weeksHopkins symptom checklist
Sleep duration, quality and awakening36 weeksActigraphy
Pain intensity36 weeksVAS scale
Medication use36 weeksRegistered analgetic usage
Self-reported memory and concentration impairments36 weeksEveryday Memory Questionnaire
Self-reported cognitive intrusion36 weeksQuestionnaire
Quality of life36 weeksEQ-5D

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026